Single Ascending Dose Study to Investigate the Safety and Pharmacokinetics of XC101-D13H in Healthy Adult Subjects
Clinical trial NCT04104399 · UNKNOWN
Trial details
- NCT number
- NCT04104399
- Sponsor
- Xoc Pharmaceuticals
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-10-08
- Primary completion
- 2022-01-28
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.